Your current location:HOME >style >Why Amylyx is pulling ALS drug Relyvrio from US market after study 正文
TIME:2024-05-21 21:19:48 Source: Internet compilationEdit:style
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Jon Wysocki dead at 53: Staind drummer passes away2024-05-21 20:57
Beijing opposes Burns' definition of Sino2024-05-21 20:49
Wang's NZ visit comes at pivotal time in relations, analysts say2024-05-21 20:47
DPP 'responsible' for hindered cross2024-05-21 20:46
How Diddy made himself the 'victim' in apology video where he does not mention ex2024-05-21 20:34
China's courts successfully serve and protect innovation2024-05-21 20:33
Foreign Ministry gets new spokesman2024-05-21 20:26
Xi congratulates Zardari on election as Pakistani president2024-05-21 19:40
Tom Brady and Jay2024-05-21 18:51
China continues improving environmental quality despite challenges2024-05-21 18:40
Investigators return to Long Island home of Gilgo Beach serial killing suspect2024-05-21 21:17
Washington manipulates freedom of speech, report finds2024-05-21 20:54
China continues Sky Net anti2024-05-21 20:39
Global South main force behind reforming international order, Wang says2024-05-21 20:22
Investigators return to Long Island home of Gilgo Beach serial killing suspect2024-05-21 19:56
Deputies urged to help advance modernization2024-05-21 19:43
China slams India's tunnel inauguration in border area2024-05-21 19:39
Top adviser reaffirms opposition to 'Taiwan independence'2024-05-21 19:33
Seven sneaky clauses in estate agent contracts that can cost you dear2024-05-21 19:22
U.S. chip firms urge Biden administration to approve sales to China as ban backfires2024-05-21 18:38